🔗 Share this article

The top legal official in Texas Paxton is suing the producers of Tylenol, claiming the corporations concealed potential risks that the pain reliever created to children's brain development.

This legal action arrives a month after Donald Trump advocated an unverified association between taking Tylenol - referred to as acetaminophen - during pregnancy and autism in young ones.

The attorney general is filing suit against Johnson & Johnson, which formerly manufactured the medication, the sole analgesic approved for expectant mothers, and the current manufacturer, which currently produces it.

In a declaration, he claimed they "misled consumers by making money from discomfort and marketing drugs regardless of the risks."

The manufacturer asserts there is insufficient reliable data tying Tylenol to autism spectrum disorder.

"These manufacturers lied for decades, deliberately risking millions to increase profits," the attorney general, a Republican, said.

The company stated officially that it was "seriously troubled by the spread of false claims on the reliability of paracetamol and the possible consequences that could have on the health of American women and children."

On its official site, the company also mentioned it had "consistently assessed the applicable studies and there is no credible data that demonstrates a established connection between using paracetamol and autism."

Groups representing physicians and medical practitioners agree.

The American College of Obstetricians and Gynecologists has declared acetaminophen - the main ingredient in Tylenol - is among limited choices for expectant mothers to manage pain and elevated temperature, which can pose serious health risks if ignored.

"In over twenty years of studies on the consumption of paracetamol in gestation, zero credible investigations has successfully concluded that the use of acetaminophen in any trimester of gestation leads to neurodevelopmental disorders in young ones," the association commented.

This legal action references latest statements from the Trump administration in arguing the medication is reportedly hazardous.

Recently, Trump caused concern from public health officials when he advised expectant mothers to "struggle intensely" not to use acetaminophen when unwell.

The FDA then released a statement that medical professionals should think about restricting the consumption of Tylenol, while also stating that "a proven link" between the medication and autism in minors has remains unverified.

Health Secretary RFK Jr, who manages the FDA, had pledged in April to undertake "comprehensive study program" that would determine the cause of autism spectrum disorder in a short period.

But experts warned that finding a unique factor of autism spectrum disorder - thought by researchers to be the outcome of a complicated interplay of genetic and external influences - would prove challenging.

Autism spectrum disorder is a type of lifelong neurodivergence and condition that affects how people experience and interact with the world, and is identified using doctors' observations.

In his lawsuit, the attorney general - a Trump ally who is campaigning for US Senate - claims the manufacturer and Johnson & Johnson "deliberately disregarded and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

The case aims to force the corporations "destroy any commercial messaging" that states acetaminophen is reliable for pregnant women.

The Texas lawsuit parallels the grievances of a assembly of mothers and fathers of children with autism and ADHD who filed suit against the producers of acetaminophen in 2022.

A federal judge dismissed the lawsuit, declaring studies from the plaintiffs' authorities was inconclusive.